Clinical features and posttreatment monitoring of dogs administered rivaroxaban (2018-2020): 19 cases.

Objective: To describe a population of sick dogs administered rivaroxaban monitored with a rivaroxaban-calibrated anti-Xa activity assay (aXa).

Design: Descriptive retrospective study.

Setting: Two veterinary teaching hospitals.